These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25628939)

  • 1. Antitumor effects of WNT2B silencing in GLUT1 overexpressing cisplatin resistant head and neck squamous cell carcinoma.
    Li SJ; Yang XN; Qian HY
    Am J Cancer Res; 2015; 5(1):300-8. PubMed ID: 25628939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of GLUT1 on the survival of head and neck squamous cell carcinoma.
    Li S; Yang X; Wang P; Ran X
    Cell Physiol Biochem; 2013; 32(3):624-34. PubMed ID: 24022001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of glucose transporter 1 (GLUT1) chemosensitized head and neck cancer cells to cisplatin.
    Wang YD; Li SJ; Liao JX
    Technol Cancer Res Treat; 2013 Dec; 12(6):525-35. PubMed ID: 23617290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCR4 enhances cisplatin resistance of human tongue squamous cell carcinoma.
    Zhuang XM; Zhou B
    J Oral Pathol Med; 2019 Feb; 48(2):122-128. PubMed ID: 30554431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth inhibition and chemo-radiosensitization of head and neck squamous cell carcinoma (HNSCC) by survivin-siRNA lentivirus.
    Khan Z; Khan AA; Prasad GB; Khan N; Tiwari RP; Bisen PS
    Radiother Oncol; 2016 Feb; 118(2):359-68. PubMed ID: 26747757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of β-catenin in cisplatin resistance, relapse and prognosis of head and neck squamous cell carcinoma.
    Roy S; Kar M; Roy S; Saha A; Padhi S; Banerjee B
    Cell Oncol (Dordr); 2018 Apr; 41(2):185-200. PubMed ID: 29243047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipose-derived stem cell conditioned medium attenuates cisplatin-triggered apoptosis in tongue squamous cell carcinoma.
    Chiu YJ; Yang JS; Hsu HS; Tsai CH; Ma H
    Oncol Rep; 2018 Feb; 39(2):651-658. PubMed ID: 29207154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing Wnt2B by siRNA interference inhibits metastasis and enhances chemotherapy sensitivity in ovarian cancer.
    Wang H; Fan L; Xia X; Rao Y; Ma Q; Yang J; Lu Y; Wang C; Ma D; Huang X
    Int J Gynecol Cancer; 2012 Jun; 22(5):755-61. PubMed ID: 22635028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of cyclin D1 by shRNA is associated with enhanced sensitivity to conventional therapies for head and neck squamous cell carcinoma.
    Kothari V; Mulherkar R
    Anticancer Res; 2012 Jan; 32(1):121-8. PubMed ID: 22213296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin-induced growth arrest of head and neck cancer cells correlates with increased expression of p16 and p53.
    Yip HT; Chopra R; Chakrabarti R; Veena MS; Ramamurthy B; Srivatsan ES; Wang MB
    Arch Otolaryngol Head Neck Surg; 2006 Mar; 132(3):317-26. PubMed ID: 16549753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anthelmintic mebendazole enhances cisplatin's effect on suppressing cell proliferation and promotes differentiation of head and neck squamous cell carcinoma (HNSCC).
    Zhang F; Li Y; Zhang H; Huang E; Gao L; Luo W; Wei Q; Fan J; Song D; Liao J; Zou Y; Liu F; Liu J; Huang J; Guo D; Ma C; Hu X; Li L; Qu X; Chen L; Yu X; Zhang Z; Wu T; Luu HH; Haydon RC; Song J; He TC; Ji P
    Oncotarget; 2017 Feb; 8(8):12968-12982. PubMed ID: 28099902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisense cyclin D1 enhances sensitivity of head and neck cancer cells to cisplatin.
    Wang MB; Yip HT; Srivatsan ES
    Laryngoscope; 2001 Jun; 111(6):982-8. PubMed ID: 11404608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic Interaction of the Class IIa HDAC Inhibitor CHDI0039 with Bortezomib in Head and Neck Cancer Cells.
    Schrenk C; Bollmann LM; Haist C; Bister A; Wiek C; Wecker M; Roth D; Petzsch P; Köhrer K; Hamacher A; Hanenberg H; Fluegen G; Kassack MU
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA Hottip modulates high-glucose-induced inflammation and ECM accumulation through miR-455-3p/WNT2B in mouse mesangial cells.
    Zhu XJ; Gong Z; Li SJ; Jia HP; Li DL
    Int J Clin Exp Pathol; 2019; 12(7):2435-2445. PubMed ID: 31934070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of c-Fos in the Promotion of Cancer Stem-like Cell Properties in Head and Neck Squamous Cell Carcinoma.
    Muhammad N; Bhattacharya S; Steele R; Phillips N; Ray RB
    Clin Cancer Res; 2017 Jun; 23(12):3120-3128. PubMed ID: 27965308
    [No Abstract]   [Full Text] [Related]  

  • 16. Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patients.
    Schrader CH; Kolb M; Zaoui K; Flechtenmacher C; Grabe N; Weber KJ; Hielscher T; Plinkert PK; Hess J
    Mol Cancer; 2015 May; 14():107. PubMed ID: 25990935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological inhibition of Bmi1 by PTC-209 impaired tumor growth in head neck squamous cell carcinoma.
    Wang Q; Li Z; Wu Y; Huang R; Zhu Y; Zhang W; Wang Y; Cheng J
    Cancer Cell Int; 2017; 17():107. PubMed ID: 29200967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of cyclin D1 correlates with sensitivity to cisplatin in squamous cell carcinoma cell lines of the head and neck.
    Akervall J; Kurnit DM; Adams M; Zhu S; Fisher SG; Bradford CR; Carey TE
    Acta Otolaryngol; 2004 Sep; 124(7):851-7. PubMed ID: 15484403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired cisplatin resistance in the head-neck cancer cell line Cal27 is associated with decreased DKK1 expression and can partially be reversed by overexpression of DKK1.
    Gosepath EM; Eckstein N; Hamacher A; Servan K; von Jonquieres G; Lage H; Györffy B; Royer HD; Kassack MU
    Int J Cancer; 2008 Nov; 123(9):2013-9. PubMed ID: 18688867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of cyclin D1 expression by cyclin D1 shRNAs in human oral squamous cell carcinoma cells is associated with increased cisplatin chemosensitivity.
    Zhou X; Zhang Z; Yang X; Chen W; Zhang P
    Int J Cancer; 2009 Jan; 124(2):483-9. PubMed ID: 18942709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.